PLSE · Pulse Biosciences, Inc. · Executive Compensation
Market Cap
$3.79B
Shares
71.32M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul A. LaViolette | Chief Executive Officer and Co-Chairman | $7,427,899 |
| Paul LaViolette | CEO | $7,427,899 |
| Jon Skinner | Chief Financial Officer | $2,843,000 |
| Darrin R. Uecker | Chief Technology Officer and Director | $869,889 |
| Kevin P. Danahy | Former Chief Commercial Officer | $854,577 |
| Burke T. Barrett | Former Chief Executive Officer and Former Director | — |
| Mitchell E. Levinson | Former Chief Strategy Officer and Former Director | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Burke T. Barrett | Former Chief Executive Officer and Director | $8,435,605 |
| Kevin P. Danahy | Chief Commercial Officer | $616,410 |
| Darrin R. Uecker | Chief Technology Officer and Director | $616,410 |
| Paul A. LaViolette | Chief Executive Officer and Co-Chairman | — |
| Paul LaViolette | CEO | — |
| Jon Skinner | Chief Financial Officer | — |
| Mitchell E. Levinson | Former Chief Strategy Officer and Former Director | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kevin P. Danahy | Chief Commercial Officer | $5,864,450 |
| Darrin R. Uecker | Chief Technology Officer and Director | $5,390,028 |
| Mitchell E. Levinson | Chief Strategy Officer | $1,694,562 |
| Jon Skinner | Chief Financial Officer | — |
| Paul LaViolette | CEO | — |
| Burke T. Barrett | Former Chief Executive Officer and Director | — |
| Paul A. LaViolette | Chief Executive Officer and Co-Chairman | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kevin P. Danahy | Chief Executive Officer | $2,263,256 |
| Darrin R. Uecker | Chief Technology Officer and Director | $487,235 |
| Mitchell E. Levinson | Chief Strategy Officer | $361,338 |
| Paul A. LaViolette | Chief Executive Officer and Co-Chairman | — |
| Jon Skinner | Chief Financial Officer | — |
| Burke T. Barrett | Former Chief Executive Officer and Former Director | — |
| Paul LaViolette | CEO | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Darrin R. Uecker | Chief Technology Officer and Director | $2,286,036 |
| Mitchell E. Levinson | Chief Strategy Officer and Director | $1,062,416 |
| Kevin P. Danahy | Chief Executive Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Sandra Gardiner | Executive Vice President, Finance and Administration and Chief Financial Officer | $2,097,566 |
| Darrin R. Uecker | President, Chief Executive Officer and Director | $1,420,301 |
| Brian B. Dow | Former Senior Vice President, Finance and Administration and Chief Financial Officer | $438,212 |
| Edward A. Ebbers | Executive Vice President and General Manager, Dermatology | $419,851 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Darrin R. Uecker | President, Chief Executive Officer and Director | $569,437 |
| Brian B. Dow | Former Senior Vice President, Finance and Administration and Chief Financial Officer | $381,393 |
| Edward A. Ebbers | Executive Vice President and General Manager, Dermatology | $303,132 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Darrin R. Uecker | President, Chief Executive Officer and Director | $13,626,047 |
| Brian B. Dow | Former Senior Vice President, Finance and Administration and Chief Financial Officer | $2,101,288 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Liane Teplitsky | Chief Operating Officer | Appointed | 2026-04-09 |
| Liane R. Teplitsky | Chief Operating Officer | Appointed | 2026-04-09 |
| Kevin P. Danahy | Chief Commercial Officer | Resigned | 2026-02-27 |
| Maria Sainz | Board of Directors | Appointed | 2026-01-09 |
| Steven T. Weber | Vice President of Accounting and Global Corporate Controller | Appointed | 2025-07-14 |
| Jon Skinner | Chief Financial Officer | Appointed | 2025-02-04 |
| Paul A. LaViolette | Chief Executive Officer and President | Appointed | 2025-01-13 |
| Burke T. Barrett | Board of Directors | Resigned | 2024-12-06 |
| Burke T. Barrett | President and Chief Executive Officer | Resigned | 2024-12-06 |
| Manmeet Soni | member of the Strategic Advisory Committee | Appointed | 2024-08-12 |
| Paul A. LaViolette | Chairman of the Board's newly created Strategic Advisory Committee | Appointed | 2024-08-12 |
| Mahkam Zanganeh | member of the Strategic Advisory Committee | Appointed | 2024-08-12 |
| Paul A. LaViolette | Co-Chairman of the Board | Appointed | 2024-08-12 |
| Paul A. LaViolette | member of the Company's Board of Directors | Appointed | 2024-08-12 |
Key facts
CIK
1625101
CUSIP
74587B101
13F (30d)
34 filings
34 filers
Visit website
Investor relations